See All Slides - tctmd.com

Slides

Presentation TCT 2013

TRILOGY-ACS Recap and Emerging Data: Implications for Current Prasugrel Use

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

Pro Position: Randomized Trial Results Support Incorporating FFR Into Most PCI Procedures!

Presenter: Habib Samady

October 31, 2013

Presentation TCT 2013

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Presenter: Freek Verheugt

October 31, 2013

Presentation TCT 2013

Pro Position: Put Your Biases Aside – We Did the Study!

Presenter: Holger Thiele

October 31, 2013

Presentation TCT 2013

Case 4: The Sheathless Approach to a Complex PCI

Presenter: Margaret McEntegart

October 31, 2013

Presentation TCT 2013

Defining and Measuring Frailty: An Important Assessment Feature of High-Risk TAVR Patients

Presenter: Philip Green

October 31, 2013

Presentation TCT 2013

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

Genetic Testing is of Clear Clinical Utility in Selected Patients

Presenter: Jessica Mega

October 31, 2013

Presentation TCT 2013

I'm Sure: Cangrelor Is Required In Addition!

Presenter: Gregg Stone

October 31, 2013

Presentation TCT 2013

Case #1: iFR Case

Presenter: Sayan Sen

October 31, 2013

Advertisement

Slides

TRILOGY-ACS Recap and Emerging Data: Implications for Current Prasugrel Use

Pro Position: Randomized Trial Results Support Incorporating FFR Into Most PCI Procedures!

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Pro Position: Put Your Biases Aside – We Did the Study!

Case 4: The Sheathless Approach to a Complex PCI

Defining and Measuring Frailty: An Important Assessment Feature of High-Risk TAVR Patients

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Genetic Testing is of Clear Clinical Utility in Selected Patients

I'm Sure: Cangrelor Is Required In Addition!

Case #1: iFR Case

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content